Yes, it is possible to survive neuroendocrine cancer. Neuroendocrine cancer (also known as neuroendocrine tumours or NETs) is a type of cancer that affects cells that release hormones into the bloodstream. It is a rare type of cancer that usually begins in the digestive system, lungs, or pancreas.
Treatment for neuroendocrine cancer will depend on the size and location of the tumor, as well as the individual patient's medical history. Surgery is often the first line of treatment, and in some cases, it may be possible to remove the entire tumor. Radiation and chemotherapy may also be used to reduce tumor size before or after surgery. Targeted therapies, such as everolimus, may be used to slow the growth of certain types of neuroendocrine tumors.
Although neuroendocrine cancer can be a very serious condition, many people have been able to survive it. With early diagnosis and appropriate treatment, the prognosis for neuroendocrine cancer is often positive. Studies have found that the five-year survival rate for neuroendocrine cancer can be as high as 87%. However, it is important to note that survival rates can vary depending on the individual patient and the type and stage of the disease.
It is important to seek medical attention if you experience any symptoms of neuroendocrine cancer, such as abdominal pain, vomiting, unexplained weight loss, or changes in bowel habits. Early diagnosis and treatment can greatly improve the chances of survival.